Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Signorelli

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2021
Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|June 11, 2021
Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination siteC Signorelli, A Odone, V Gianfredi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2021
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2022
Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third studyF Nelli, D Giannarelli, A Fabbri, et al.
ESMO Open|December 23, 2021
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On studyE M Ruggeri, F Nelli, A Fabbri, et al.
Vaccine|May 7, 2018
Attitudes towards compulsory vaccination in Italy: Results from the NAVIDAD multicentre studyM R Gualano, F Bert, G Voglino, et al.
ESMO Open|July 16, 2025
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world datasetV Daprà, A Gandini, F Schietroma, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|October 20, 2017
Strategies for Disease Prevention and Health Promotion in Urban Areas: The Erice 50 CharterD D'Alessandro, S Arletti, A Azara, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|March 1, 2017
Water safety in healthcare facilities. The Vieste CharterL Bonadonna, M Cannarozzi de Grazia, S Capolongo, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patientsA Puccini, F Grillo, M Fassan, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 23, 2021
Effects of active cancer treatment on safety and immunogenicity of COVID-19 mRNA-BNT162b2 vaccine: preliminary results from the prospective observational Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|June 11, 2021
Application of the "immunization islands" model to improve quality, efficiency and safety of a COVID-19 mass vaccination siteC Signorelli, A Odone, V Gianfredi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2021
Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On studyF Nelli, A Fabbri, A Onorato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2022
Immunogenicity and early clinical outcome after two or three doses of SARS-CoV-2 mRNA-BNT162b2 vaccine in actively treated cancer patients: results from the prospective observational Vax-On-Third studyF Nelli, D Giannarelli, A Fabbri, et al.
ESMO Open|December 23, 2021
Antineoplastic treatment class modulates COVID-19 mRNA-BNT162b2 vaccine immunogenicity in cancer patients: a secondary analysis of the prospective Vax-On studyE M Ruggeri, F Nelli, A Fabbri, et al.
Vaccine|May 7, 2018
Attitudes towards compulsory vaccination in Italy: Results from the NAVIDAD multicentre studyM R Gualano, F Bert, G Voglino, et al.
ESMO Open|July 16, 2025
Prognostic impact and clinical management of pT4N0 colon cancer: data from a large, multicenter, international, real-world datasetV Daprà, A Gandini, F Schietroma, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|October 20, 2017
Strategies for Disease Prevention and Health Promotion in Urban Areas: The Erice 50 CharterD D'Alessandro, S Arletti, A Azara, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|March 1, 2017
Water safety in healthcare facilities. The Vieste CharterL Bonadonna, M Cannarozzi de Grazia, S Capolongo, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ItaLynch: an ongoing Italian study to evaluate the feasibility of mainstreaming the diagnosis of Lynch syndrome in colorectal cancer patientsA Puccini, F Grillo, M Fassan, et al.
Pageof 16